Nursing
News, opinions and meeting coverage in hospital-based medicine.
<ѻýҕl>Lung Foam Disappoints in COPDѻýҕl>
SAN DIEGO -- A trial of hydrogel-based lung volume reduction therapy in patients with chronic obstructive pulmonary disease (COPD) complicated by emphysema failed to show consistent enough results and has been abandoned by the agent's developer, researchers said here.
May 20, 2014
<ѻýҕl>FDA Slashes Starting Dose for Lunestaѻýҕl>
SILVER SPRING, Md. -- Patients starting on the sleep drug eszopiclone (Lunesta) should take no more than 1 mg at bedtime -- one-third the current label-recommended dose -- because of the risk of next-day impairment, the FDA said Thursday.
May 15, 2014
<ѻýҕl>Fewer False Positives With ECG for Young Athletesѻýҕl>
SAN FRANCISCO -- When screening high school athletes for cardiac abnormalities, an electrocardiogram (ECG) interpreted using athlete-specific criteria had a lower false-positive rate than a history and physical examination, researchers found.
May 11, 2014
<ѻýҕl>Leadless Pacing Shows Promise, But Hits Snagsѻýҕl>
SAN FRANCISCO -- Longer-term results from the first-in-man study of the Nanostim leadless pacemaker showed the device continued to work as expected, but a postmarketing study in Europe has been temporarily halted following reports of perforations and deaths.
May 10, 2014
<ѻýҕl>Nasogastric Tube May Be Obsolete for GI Bleedsѻýҕl>
CHICAGO -- Placement of a nasogastric tube for determining treatment of patients with upper gastrointestinal bleeding may be unnecessary since almost all these patients will eventually undergo an endoscopic procedure, researchers argued here.
May 07, 2014
<ѻýҕl>CardioBuzz: Is Marijuana Bad for Your Heart?ѻýҕl>
Whether marijuana actually causes cardiovascular problems remains unclear, a situation that was not necessarily helped by a study based on 35 reports of cannabis-related complications in France, a country with about 1.2 million recreational users.
Apr 24, 2014
<ѻýҕl>Fatty Liver Tied to Diabetes, Atherosclerosisѻýҕl>
LONDON -- Non-alcoholic fatty liver disease (NAFLD) is an independent predictor of both type 2 diabetes and carotid atherosclerosis, according to two studies presented here at the annual meeting of the European Association for the Study of the Liver.
Apr 11, 2014